# Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer

> **NCT06684652** · NA · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** 3TB+6SB
- **PROCEDURE:** 3TB+12SB

## Key facts

- **NCT ID:** NCT06684652
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-09-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06684652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06684652, "Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06684652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*